Affordable Access

Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics.

Authors
  • 1
  • 1 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Austria. [email protected] , (Austria)
Type
Published Article
Journal
International journal of clinical pharmacology and therapeutics
Publication Date
Volume
45
Issue
6
Pages
328–334
Identifiers
PMID: 17595890
Source
Medline
License
Unknown

Abstract

This study demonstrates that fluvastatin ER is equally effective in inhibiting cholesterol biosynthesis when given once daily in the morning and once daily in the evening.

Statistics

Seen <100 times